In February 2022, the Indian pharmaceutical company Cadila Healthcare had the highest moving annual revenue from its cardia drug formulation Atorva, with an earning of almost 1.9 billion Indian rupees. This was closely followed by the respiratory drug Deriphyllin generating an annual revenue of over 1.8 billion rupees respectively.
Revenue of Cadila Healthcare India in February 2022, by leading therapy drug
(in billion Indian rupees)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Motilal Oswal Group. (March 8, 2022). Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph]. In Statista. Retrieved November 24, 2024, from https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees)." Chart. March 8, 2022. Statista. Accessed November 24, 2024. https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/
Motilal Oswal Group. (2022). Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees). Statista. Statista Inc.. Accessed: November 24, 2024. https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/
Motilal Oswal Group. "Revenue of Cadila Healthcare India in February 2022, by Leading Therapy Drug (in Billion Indian Rupees)." Statista, Statista Inc., 8 Mar 2022, https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/
Motilal Oswal Group, Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees) Statista, https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/ (last visited November 24, 2024)
Revenue of Cadila Healthcare India in February 2022, by leading therapy drug (in billion Indian rupees) [Graph], Motilal Oswal Group, March 8, 2022. [Online]. Available: https://www.statista.com/statistics/1096948/india-cadila-healthcare-revenue-by-therapy-drugs/